Prefer Dr Reddy, Cipla over Shasun Pharma: Sukhani

Sudarshan Sukhani, s2analytics.com advises to switch from Shasun Pharmaceuticals to Dr Reddy and Cipla.
 
Sukhani told CNBC-TV18, “Shasun Pharmaceuticals had a very poor performance. Also consider the fact that pharmaceuticals as such have been an excellent sector to be in, it has underperformed the index, underperformed its own peer sectors, everything. I do not think there is any purpose in staying in this stock. It is far better you switch.”
 
He further added, “One can switch from Shasun Pharmaceuticals to either Dr Reddy or Cipla, use the same amount of money that you receive on selling it and buy any one of these two shares that is probably a much better approach.”